Skip to content

D&A at other companies

AutoNation logo
AutoNationAN
$63M+1.9%
Terex logo
TerexTEX
$77M+97.4%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$252K-34.2%
Chime Financial, Inc. Class A Common Stock logo
Chime Financial, Inc. Class A Common StockCHYM
$4.17M+9.5%
Citigroup logo
CitigroupC
$1.12B+6.2%
LyondellBasell Industries N.V. logo
LyondellBasell Industries N.V.LYB
$0

Other financials

Income statement

See full
Revenue$745.6M+9.9%
Gross profit$275.1M+7.8%
Operating income$90.5M-17.6%
Net income$47.6M-29.3%
EPS (diluted)$0.78-29.1%

Balance sheet

See full
Cash & equivalents$1.0B+245%
Total debt$2.1B+84.9%
Total equity$2.2B+14.7%
Total assets$5.6B+33.4%

Cash flow

See full
Operating cash flow$46.9M+32.5%
CapEx$13.7M+87.9%
Free cash flow$33.2M+18.1%

Valuation

See full
Market cap$6.47B-16.7%
Enterprise value$7.6B-11.5%
P/E31.2×+2.7×
P/S2.2×-0.6×

Profitability

See full
Gross margin36.7%-1.3pp
Operating margin13.5%-2.9pp
Net margin7.1%-2.9pp
FCF margin7.5%-3.3pp

Returns & leverage

See full
Return on equity10.1%-5.2pp
Debt / equity+0.4×
Current ratio+1.1×

Where this comes from

Reported directly by ESAB in its filing.

Tagged under the XBRL concept esab:DeferredTaxAssetPropertyPlantAndEquipmentAndGoodwillAndIntangibleAssets.

The official record: ESAB’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about ESAB's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ESAB's D&A?
ESAB (ESAB) reported D&A of $6.54M in Q4 2025.
What is the long-term trend for ESAB's D&A?
Over 3 years (2022 to 2025), ESAB's D&A has grown at a -10.5% compound annual growth rate (CAGR), from $9.12M to $6.54M.
What does D&A mean?
This metric tracks the non-cash charge representing the systematic allocation of the cost of tangible and intangible assets over their useful lives. It reflects the wear and tear or obsolescence of the company's capital base used in manufacturing operations. Investors monitor this to evaluate capital intensity and the reinvestment requirements of the business.